EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy and Safety of Combination Therapy of Microneedling Radiofrequency, In‐Office and Home‐Based Topical Cysteamine in Refractory Melasma: A Split Face, Vehicle‐Control, Randomized Control Trial

Ya-Wen Tsai, Jeng-Hsien Lin, Yi-Jing Lai, Tzu-Li Liu iD, Chau Yee Ng

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.16661 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Ya-Wen Tsai und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Cysteamine, Melanosis, Radiofrequency Therapy, Dry Needling. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: WOH medical foundation, Scientis Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Refractory melasma remains a challenge in dermatology, necessitating the exploration of innovative treatments.

Aims

This study aims to evaluate the efficacy and safety of combining radiofrequency microneedling (RFM) with Cysteamine cream, applied both in‐office and as a part of a home‐care regimen, to treat refractory melasma. Patients/Methods A vehicle‐controlled, split‐face trial was conducted on 30 Fitzpatrick skin types III and IV participants. Subjects received RFM and Cysteamine serum on one side of the face and RFM with saline on the contralateral side. Additionally, a random half‐added Cysteamine cream was applied at home. The modified Melasma Area and Severity Index and VISIA skin analysis were used for assessment.

Results

Significant improvement in melasma severity and skin texture was noted on the sides treated with RFM and Cysteamine, including observable benefits from both in‐office and home‐based Cysteamine use with minimal adverse effects.

Conclusions

The combined approach of RFM with Cysteamine provides a promising and safe modality for managing refractory melasma, showing notable improvements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CysteamineMelanosisRadiofrequency TherapyDry NeedlingHumansFemaleAdultTreatment OutcomeMiddle AgedCombined Modality TherapyNeedlesMaleAdministration, CutaneousSeverity of Illness IndexYoung AdultSkin CreamHome Care ServicesPercutaneous Collagen Induction

Stichwörter der Autor:innen

cysteamineisobionic‐amide complexmelasmamicroneedling radiofrequencysplit‐face trial

Substanzen

Cysteamine

Autor:innen und Institutionen

  • School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Department of Dermatology, Chang Gung Memorial Hospital, Taipei, Linkou, Taiwan.
  • Department of Dermatology and Aesthetic Medicine Center, Jen-Ai Hospital, Tai Chung, Taiwan.
  • Dr. LIN's Dermatological Clinic, Kaohsiung City, Taiwan.
  • Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
  • Vitiligo Clinic and Pigment Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan.

ORCID-Profile: Tzu-Li Liu

Förderung

  • WOH medical foundation
  • Scientis Pharma

Zitieren

APA

Tsai, Y. W., Lin, J. H., Lai, Y. J., Liu, T. L., & Ng, C. Y. (2025). Efficacy and Safety of Combination Therapy of Microneedling Radiofrequency, In‐Office and Home‐Based Topical Cysteamine in Refractory Melasma: A Split Face, Vehicle‐Control, Randomized Control Trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16661

Vancouver

Tsai YW, Lin JH, Lai YJ, Liu TL, Ng CY. Efficacy and Safety of Combination Therapy of Microneedling Radiofrequency, In‐Office and Home‐Based Topical Cysteamine in Refractory Melasma: A Split Face, Vehicle‐Control, Randomized Control Trial. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.16661

BibTeX
@article{Tsai2025,
  author = {Tsai, Ya-Wen and Lin, Jeng-Hsien and Lai, Yi-Jing and Liu, Tzu-Li and Ng, Chau Yee},
  title = {Efficacy and Safety of Combination Therapy of Microneedling Radiofrequency, In‐Office and Home‐Based Topical Cysteamine in Refractory Melasma: A Split Face, Vehicle‐Control, Randomized Control Trial},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.16661}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche